SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2025ACC: 0001415889-25-014261
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-9.35K
Net shares
Net seller
$88.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.35K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−9.35K
Price / share
$9.45
Trade value
$88.34K
% of position
2.5%
5/20/2025
374.14K→364.79K
Total
Net shares
−9.35K
Net value
-$88.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2025 | F · Tax Withholding | −9.35K | $9.45 | $88.34K | 2.5% | 374.14K | 364.79K |
| Total | −9.35K | -$88.34K | ||||||
Derivative Transactions0
No derivative transactions reported